Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).

Silvio DaneseSéverine VermeirePaul HellsternRemo PanaccioneGerhard RoglerGerald FraserAnna KohnPierre DesreumauxRupert W L LeongGail M ComerFabio CataldiAnindita BanerjeeMary K MaguireCheryl LiNatalie RathJean BeebeStefan Schreiber

Published in: Gut (2017)

NCT01287897 and NCT01345318.

Keyphrases

open label
study protocol
clinical trial
phase ii
phase iii
radiation therapy